FDA Approves Donor Lung Preservation Device That May Result in More Lung Transplants

Silver Spring, Maryland—(ENEWSPF)—August 12, 2014. Today, the U.S. Food and Drug Administration approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for preserving donated lungs that do not initially meet the standard criteria for lung transplantation but may be transplantable if there is more time to observe and evaluate the organ’s function to determine whether the lung is viable for transplantation.

Lung transplantation is a primary option in the care of patients with…